Investment outlooks for 2026 and A-share company target prices from foreign institutions including Morgan Stanley, Morgan Stanley China (‘Little Morgan’), and UBS

Omnivision Technologies recently launched its new OV50R CMOS image sensor, featuring a 1/1.3-inch optical format, 50-megapixel resolution, and 1.2μm pixel size—positioned for high-end main camera applications across smartphones, action cameras, vlog cameras, and portable cameras. The OV50R has completed sampling and is scheduled to enter mass production in Q1 2026, potentially further enhancing the company’s penetration into the premium imaging market. JPMorgan forecasts net profit growth of 33.82% for 2025 and 40.05% for 2026. UBS: Global tech stocks set for a new rally in 2026! UBS upgrades ratings on four companies to ‘Buy’! In its 2026 investment outlook, UBS states that the A-share market stands at a positive inflection point marked by improving earnings growth and valuation re-rating. It expects A-share earnings growth to accelerate from 6% this year to 8% next year. This acceleration is driven by two key factors: first, faster nominal GDP growth and a narrowing year-on-year decline in the Producer Price Index (PPI) are expected to jointly boost listed companies’ revenues; second, the implementation of supportive macroeconomic policies and continued healthy deleveraging within the corporate sector may drive a modest recovery in overall profitability. Moreover, the current A-share equity risk premium—above its historical average—suggests significant potential for valuation re-rating. Additionally, recent market corrections stem largely from global tech-sector adjustments and short-term trading congestion—but present an opportune moment to position for medium-term re-rating logic. UBS’s Global Strategy Team believes global tech stocks will enter a new upswing in 2026. Investment recommendations emphasize four themes: technological self-reliance, consumption recovery, sectors benefiting from ‘anti-overcompetition’ policies (e.g., photovoltaics, lithium batteries, chemicals), and Chinese enterprises expanding overseas. Key risks include escalation of U.S.-China trade tensions, ongoing property sector weakness, and a potential global AI bubble burst. Our analysis shows that since October this year, UBS has issued updated ratings on 196 A-share companies: maintaining ‘Buy’ ratings on 131, upgrading four to ‘Buy’, and one to ‘Neutral’. UBS also initiated coverage on 15 companies, assigning ‘Buy’ ratings to Great Wall Motor, Edi Biotech, and Longhua Technology. Regarding target price upside, UBS’s latest target price for Aipu Medical is RMB 118 per share—versus its closing price of RMB 61.28 on December 5—implying over 90% upside potential. Morgan Stanley, Goldman Sachs, and Citigroup: A-share valuations remain attractive! Stock selection is critical! Wang Ying, Chief China Equity Strategist at Morgan Stanley, notes that in 2025, China’s equity market completed a decisive valuation recovery—driven by stronger consumer support, ‘anti-overcompetition’ policies bolstering confidence, growing global recognition of Chinese enterprises’ competitiveness, and marginally improved geopolitical conditions. The MSCI China Index P/E ratio rose from 9x to over 13x. Looking ahead to 2026, further substantial expansion in overall market valuations appears limited; index gains may be in the low single digits, with core momentum shifting toward mid-single-digit earnings growth. Investment focus must therefore pivot from ‘valuation expansion’ to ‘earnings-driven returns’, seeking alpha through selective stock picking and thematic exposure.

Tu Caijing | PPG posted ‘zero growth’ in 2025—stock price hit! Emergency ‘cost scalpel’ launched—can it turn things around this year?

On profitability, the company reported diluted EPS of $1.34 and adjusted EPS of $1.51—slightly below the consensus estimate of $1.58. However, net income surged dramatically, rising from $2 million ($0.01 per share) a year ago to $302 million. During the quarter, PPG continued returning capital to shareholders, completing approximately $100 million in share repurchases. In Q4, PPG’s three core business segments delivered differentiated growth—with standout performance in key areas. The Global Architectural Coatings segment achieved net sales growth of 8% to $951 million, as higher selling prices and favorable currency effects offset the impact of divesting its Russian architectural coatings business. EBITDA rose 14% to $164 million, with margins improving to 17.2%. Regionally, organic sales grew at a high single-digit rate in Latin America and the Asia-Pacific region; retail sales in Mexico remained robust, and project-related sales continued recovering—though European volume declines partially offset overall growth momentum. The Performance Coatings segment recorded net sales growth of 5% to $1.32 billion, with organic sales up 3%. Subsegment highlights included record-high aerospace coatings sales—delivering double-digit organic growth—and 11 consecutive quarters of volume growth in protective & marine coatings, with Asia-Pacific marine volumes outpacing market growth. However, automotive refinish demand declined by a high single-digit percentage, partially offsetting these gains. Segment EBITDA fell 4% year-on-year, with margins dipping to 21.1%, primarily due to lower volumes and increased investment spending related to growth initiatives. The Industrial Coatings segment posted net sales growth of 3% to $1.64 billion, with volume growth of 5%, driven mainly by market share gains. Subsegment performance outpaced industry averages: automotive OEM coatings net sales rose 6%, and packaging coatings achieved double-digit organic sales growth. Segment EBITDA increased 6% year-on-year, with margins slightly improved versus last year—primarily driven by higher volumes and productivity gains. Tim Knavish, Chairman and CEO of PPG, stated: “We delivered our strongest organic growth of the year in Q4—a 3% increase driven by contributions from both volume and pricing—and achieved volume growth across all regions. For the full year, double-digit growth in aerospace, protective & marine coatings, and high-single-digit growth in packaging coatings underpinned solid performance. The Performance Coatings segment achieved record highs in both sales and earnings.”

UBS Cuts PPG Industries Price Target to $116.00

5 days ago

UBS Group lowered its price target for PPG Industries to $116 while maintaining a neutral rating. The company reported quarterly revenue of $4.50 billion, exceeding estimates despite slightly missing EPS expectations.

MarketBeat

2026-04-15

Sumitomo Mitsui Trust Group Inc. Cuts Position in PPG Industries, Inc. $PPG

2026-04-16

US Premarket Movers: Hims & Hers, PPG Industries, QuidelOrtho

2026-04-17

Robeco Institutional Asset Management B.V. Sells 159,769 Shares of PPG Industries, Inc.

2026-04-23

Jim Cramer Doesn’t Want You to Worry About PPG Industries (PPG) & Inflation

2026-04-29

Mizuho Securities Lifts Price Target on PPG Industries to $125 From $115, Maintains Outperform Rating